Showing results (531-540 of 593) with videos related to

Sort By:
Pageof 60
Therapeutic Advances in Neurological Disorders|February 3, 2026
Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trialsMaria-Ioanna Stefanou, Evangelos Panagiotopoulos, Anastasios Tentolouris, et al.
European Stroke Journal|May 14, 2024
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysisLina Palaiodimou, Maria-Ioanna Stefanou, Aristeidis H Katsanos, et al.
European Journal of Neurology|April 10, 2021
Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysisLina Palaiodimou, Maria-Ioanna Stefanou, Aristeidis H Katsanos, et al.
Methods of Information in Medicine|February 28, 2014
A decision support system for the treatment of patients with ventricular assist device supportE C Karvounis, M G Tsipouras, A T Tzallas, et al.
Biomed Research International|March 28, 2015
Patient-specific simulation of coronary artery pressure measurements: an in vivo three-dimensional validation study in humansPanagiotis K Siogkas, Michail I Papafaklis, Antonis I Sakellarios, et al.
Journal of Diabetes and Its Complications|January 31, 2026
Effects of GLP-1 receptor agonists on vascular dementia: a systematic review and meta-analysisMaria-Ioanna Stefanou, Anastasios Tentolouris, Evangelos Panagiotopoulos, et al.
Matrix Biology Plus|March 15, 2021
A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndromeChristoforos Odiatis, Isavella Savva, Myrtani Pieri, et al.
Biomedicines|April 23, 2022
Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease: Review and Meta-AnalysisAthanasia Athanasaki, Konstantinos Melanis, Ioanna Tsantzali, et al.
Therapeutic Advances in Neurological Disorders|September 30, 2024
Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysisMaria-Ioanna Stefanou, Lina Palaiodimou, Aikaterini Theodorou, et al.
Experimental and Therapeutic Medicine|November 3, 2022
New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review)Vasiliki Efstathiou, Maria-Ioanna Stefanou, Marina Demetriou, et al.
Pageof 60